Trials / Terminated
TerminatedNCT05510128
Evaluation of the Effectiveness of a Protocol for the Management of Female Functional Urinary Signs
Evaluation of the Effectiveness of the Application of a Protocol for the Management of Female Functional Urinary Signs in French Community Pharmacies
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- University Hospital, Angers · Other Government
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Every year, between 4 and 6 million French people are affected by a urinary infection; the vast majority of these are women. Although the diagnosis of an uncomplicated urinary tract infection is simple to make, it requires prompt medical management to relieve the symptoms. The lack of immediate of a physician can slow down the management of patients affected by this condition, and lead to an inappropriate referral of patients to the emergency services. Because of their wide availability, accessibility, and geographical distribution throughout the country, pharmacists are primary health care professionals who are regularly called upon to respond to patients with this type of infection. A national protocol exists in France, but it is very difficult to apply. The PharmaCyst' study aims to evaluate its application in community pharmacies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmacist management | When a patient comes to the pharmacy with signs of urinary burning, the following will follow: * Completion of the acute cystitis symptoms score (ACSS) questionnaire. * Measure the temperature. * Perform a urine dipstick. If the patient's temperature is normal, the urine dipstick is positive, and the absence of pain in the lumbar fossa is verified, the pharmacist can dispense an appropriate antibiotic himself. A reminder of the hygienic-dietary rules is also issued, and a communication to the patient's general practitioner will be made. |
Timeline
- Start date
- 2023-06-30
- Primary completion
- 2024-10-29
- Completion
- 2025-01-29
- First posted
- 2022-08-22
- Last updated
- 2026-03-13
Locations
14 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05510128. Inclusion in this directory is not an endorsement.